Mowry Ellen M, Glenn Justin D
Department of Neurology, Johns Hopkins School of Medicine, 600 North Wolfe Street, Pathology 627, Baltimore, MD 21287, USA.
Department of Neurology, Johns Hopkins School of Medicine, 600 North Wolfe Street, Meyer Building, Room 6-138, Baltimore, MD 21287, USA.
Neurol Clin. 2018 Feb;36(1):185-196. doi: 10.1016/j.ncl.2017.08.008.
Multiple sclerosis (MS) is a neuroinflammatory autoimmune disease of unknown etiology, although genetic components and environmental triggers are thought to collude to commence pathogenesis. Numerous investigations are now demonstrating the role of the gut microbiota in neuroinflammation and how alterations in its content may be associated with MS disease. This article explores the studies using MS rodent models to determine the roles of gut bacteria in neuroinflammatory disease, evaluate the evidence linking gut bacterial dysbiosis and MS, and give insight into potential MS therapies targeting the gut microbiota currently under investigation.
多发性硬化症(MS)是一种病因不明的神经炎症性自身免疫疾病,尽管认为遗传因素和环境触发因素共同作用引发发病机制。现在大量研究表明肠道微生物群在神经炎症中的作用,以及其组成的改变如何与MS疾病相关。本文探讨了利用MS啮齿动物模型进行的研究,以确定肠道细菌在神经炎症性疾病中的作用,评估将肠道细菌失调与MS联系起来的证据,并深入了解目前正在研究的针对肠道微生物群的潜在MS治疗方法。